Menu
GeneBe

MLIP

muscular LMNA interacting protein

Basic information

Region (hg38): 6:53929981-54266280

Previous symbols: [ "C6orf142" ]

Links

ENSG00000146147NCBI:90523OMIM:614106HGNC:21355Uniprot:Q5VWP3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis (Strong), mode of inheritance: AR
  • myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysisARCardiovascular; MusculoskeletalThe condition can involve cardiomyopathy and/or arrhythmia, and awareness may allow prompt diagnosis and mangement; Individuals may be at risk of rhabdomyolysis, and awareness may allow avoidance of precipitating factors, and prompt treatment of episodesCardiovascular; Musculoskeletal34581780; 34935254; 35672413; 35915960

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MLIP gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MLIP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
22
clinvar
1
clinvar
3
clinvar
26
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
0
Total 0 2 22 1 3

Variants in MLIP

This is a list of pathogenic ClinVar variants found in the MLIP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-54019068-A-G Inborn genetic diseases Likely benign (Aug 28, 2021)2246985
6-54124549-C-T Inborn genetic diseases Uncertain significance (Jul 05, 2023)2592594
6-54124564-C-T Inborn genetic diseases Uncertain significance (Feb 15, 2023)2484834
6-54124577-A-C Inborn genetic diseases Uncertain significance (Feb 06, 2023)2481388
6-54124591-C-A Inborn genetic diseases Uncertain significance (Feb 06, 2023)2455566
6-54124611-C-A Inborn genetic diseases Uncertain significance (Dec 21, 2022)2385022
6-54124648-T-C Inborn genetic diseases Uncertain significance (Jul 06, 2021)2283352
6-54124708-G-C Inborn genetic diseases Uncertain significance (Mar 06, 2023)2471243
6-54124758-A-T Inborn genetic diseases Uncertain significance (Feb 27, 2023)2489385
6-54124780-G-A Inborn genetic diseases Uncertain significance (Dec 27, 2023)3202958
6-54124840-T-C Inborn genetic diseases Uncertain significance (May 11, 2022)2288573
6-54124848-C-T Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis Pathogenic (Nov 29, 2022)1801322
6-54124860-G-T Inborn genetic diseases Uncertain significance (Dec 16, 2023)3203019
6-54124861-G-A Inborn genetic diseases Uncertain significance (Apr 17, 2023)2537322
6-54137630-A-G Uncertain significance (Jun 08, 2023)3253232
6-54137807-CA-C Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis Pathogenic (Nov 29, 2022)1801319
6-54137812-G-A Likely benign (Jul 01, 2024)3257587
6-54137894-A-T Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis Pathogenic (Nov 29, 2022)1801325
6-54137898-GT-G Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis Pathogenic (Nov 29, 2022)1801320
6-54149059-T-A Inborn genetic diseases Uncertain significance (May 23, 2023)2550640
6-54149075-G-A Inborn genetic diseases Conflicting classifications of pathogenicity (Apr 01, 2023)2371560
6-54149109-AT-A Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis Pathogenic (Nov 29, 2022)1801326
6-54149122-C-T Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis Pathogenic (Nov 29, 2022)1801327
6-54160375-T-A Inborn genetic diseases Uncertain significance (Oct 14, 2021)2255389
6-54160386-A-G Inborn genetic diseases Uncertain significance (Dec 11, 2023)3203148

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MLIPprotein_codingprotein_codingENST00000274897 13336299
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.16e-160.009851257030441257470.000175
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.7102662351.130.00001142964
Missense in Polyphen8488.3410.950861145
Synonymous-0.6139789.61.080.00000462895
Loss of Function0.05562424.30.9880.00000108320

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006080.000597
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.0001610.000158
Middle Eastern0.0001090.000109
South Asian0.0003290.000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for precocious cardiac adaptation to stress through integrated regulation of the AKT/mTOR pathways and FOXO1. Regulates cardiac homeostasis and plays an important role in protection against cardiac hypertrophy. Acts as a transcriptional cofactor, represses transactivator activity of ISL1 and MYOCD. {ECO:0000250|UniProtKB:A0A096MK47, ECO:0000250|UniProtKB:Q5FW52}.;

Intolerance Scores

loftool
rvis_EVS
0.24
rvis_percentile_EVS
69.51

Haploinsufficiency Scores

pHI
0.728
hipred
N
hipred_score
0.123
ghis
0.487

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mlip
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); muscle phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;negative regulation of cardiac muscle hypertrophy;positive regulation of transcription by RNA polymerase II;negative regulation of cardiac muscle hypertrophy in response to stress
Cellular component
nucleus;nuclear envelope;PML body;nuclear lumen;sarcolemma
Molecular function